Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2020

TCT 066: Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program

Presenter: Sanjeevan Pasupati

October 14, 2020

Presentation TCT 2020

TCT 057: Clinical Outcomes According to Lesion Complexity in High Bleeding Risk Patients Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear Study

Presenter: David Kandzari

October 14, 2020

Presentation JIM 2020

Onyx ONE: data, details and relevance to your clinical practice

Presenter: Gennaro Sardella

February 14, 2020

Presentation JIM 2020

Onyx in hbr-a case based

Presenter: Manoj Kumar

February 14, 2020

Presentation JIM 2020

Small Vessel Stenting - My Experience With ONYX

Presenter: Lijo Varghese

February 14, 2020

Presentation TCT 2019

The Future in Managing Patients at High Bleeding Risk

Presenter: Elvin Kedhi

September 26, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Onyx One: Results and Implications

Presenter: Azeem Latib

September 26, 2019

Presentation TCT 2019

Why Onyx One?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

Who is the High Bleeding Risk Patient?

Presenter: Daniel Simon

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Advertisement

TCT 066: Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program

TCT 057: Clinical Outcomes According to Lesion Complexity in High Bleeding Risk Patients Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear Study

Onyx ONE: data, details and relevance to your clinical practice

Onyx in hbr-a case based

Small Vessel Stenting - My Experience With ONYX

The Future in Managing Patients at High Bleeding Risk

Two Case Presentations Highlighting Relevant Patients

Onyx One: Results and Implications

Why Onyx One?

Who is the High Bleeding Risk Patient?

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content